Free Trial

Sarepta Therapeutics (SRPT) Earnings Date, Estimates & Call Transcripts

$125.00
+5.02 (+4.18%)
(As of 06/13/2024 ET)

Earnings Summary

Upcoming
Earnings Date
Aug. 7Estimated
Actual EPS
(May. 1)
$0.73 Beat By $0.84
Consensus EPS
(May. 1)
-$0.11
Skip Charts & View Estimated and Actual Earnings Data

SRPT Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

SRPT Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Sarepta Therapeutics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20243($0.55)$0.17($0.23) 
Q2 20244($0.58)$0.62($0.04) 
Q3 20244$0.50$1.39$0.93 
Q4 20244$0.71$4.20$2.20 
FY 202415$0.08$6.38$2.86 
Q1 20251$0.58$0.58$0.58 
Q2 20251$1.09$1.09$1.09 
Q3 20251$1.57$1.57$1.57 
Q4 20251$2.07$2.07$2.07 
FY 20254$5.31$5.31$5.31 
Q1 20261$1.73$1.73$1.73 

SRPT Earnings Date and Information

Sarepta Therapeutics last issued its earnings results on May 1st, 2024. The biotechnology company reported $0.73 EPS for the quarter, topping analysts' consensus estimates of ($0.11) by $0.84. The company earned $413.50 million during the quarter, compared to analysts' expectations of $375.52 million. Its revenue for the quarter was up 63.1% compared to the same quarter last year. Sarepta Therapeutics has generated $0.11 earnings per share over the last year ($0.11 diluted earnings per share) and currently has a price-to-earnings ratio of 1,136.4. Earnings for Sarepta Therapeutics are expected to grow by 173.58% in the coming year, from $2.99 to $8.18 per share. Sarepta Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, August 7th, 2024 based off prior year's report dates.

Sarepta Therapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
8/7/2024
(Estimated)
------- 
5/1/2024Q1 2024($0.11)$0.73+$0.84$0.39$375.52 million$413.50 million    
2/28/2024Q4 2023($0.03)$0.47+$0.50$0.47$387.18 million$396.80 million    
11/1/2023Q3 2023($1.63)$0.37+$2.00($0.46)$285.33 million$331.80 million    
8/2/2023Q2 2023($1.89)($0.27)+$1.62($0.27)$255.99 million$261.20 million    
5/2/2023Q1 2023($1.46)($0.97)+$0.49$2.98$241.47 million$253.50 million    
2/28/2023Q4 2022($1.28)($1.24)+$0.04($1.24)$250.51 million$258.43 million    
11/2/2022Q3 2022($1.21)($2.94)($1.73)($2.94)$234.55 million$230.30 million    
8/2/2022Q2 2022($1.07)($2.65)($1.58)($2.65)$220.08 million$233.49 million
5/4/2022Q1 2022($1.35)($1.20)+$0.15($1.20)$208.25 million$210.83 million    
3/1/2022Q4 2021($1.51)($1.42)+$0.09($1.42)$198.48 million$201.50 million    
11/3/2021Q3 2021($1.86)($0.60)+$1.26($0.60)$170.13 million$189.41 million    
8/4/2021Q2 2021($1.29)($1.02)+$0.27($1.02)$161.95 million$164.09 million    
5/5/2021Q1 2021($2.01)($2.10)($0.09)($2.10)$140.73 million$146.93 million  
3/1/2021Q4 2020($1.99)($2.40)($0.41)($2.40)$145.54 million$145.10 million  
11/5/2020Q3 2020($1.89)($2.50)($0.61)($2.50)$133.69 million$143.92 million  
8/5/2020Q2 2020($1.73)($1.93)($0.20)($1.93)$112.36 million$137.36 million  
5/6/2020Q1 2020($2.17)($0.23)+$1.94($0.23)$118.18 million$113.67 million  
2/26/2020Q4 2019($1.86)($3.16)($1.30)($3.16)$100.10 million$100.11 million  
11/7/2019Q3 2019($1.35)($1.70)($0.35)($1.70)$98.49 million$99.04 million  
8/7/2019Q2 2019($1.08)($3.74)($2.66)($3.74)$91.05 million$94.67 million  

Sarepta Therapeutics Earnings - Frequently Asked Questions

When is Sarepta Therapeutics's earnings date?

Sarepta Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, August 7th, 2024 based off last year's report dates. Learn more on SRPT's earnings history.

Did Sarepta Therapeutics beat their earnings estimates last quarter?

In the previous quarter, Sarepta Therapeutics (NASDAQ:SRPT) reported $0.73 earnings per share (EPS) to beat the analysts' consensus estimate of ($0.11) by $0.84. Learn more on analysts' earnings estimate vs. SRPT's actual earnings.

How can I listen to Sarepta Therapeutics's earnings conference call?

The conference call for Sarepta Therapeutics's latest earnings report can be listened to online. Listen to Conference Call

How can I read Sarepta Therapeutics's conference call transcript?

The conference call transcript for Sarepta Therapeutics's latest earnings report can be read online. Read Transcript

How much revenue does Sarepta Therapeutics generate each year?

Sarepta Therapeutics (NASDAQ:SRPT) has a recorded annual revenue of $1.24 billion.

How much profit does Sarepta Therapeutics generate each year?

Sarepta Therapeutics (NASDAQ:SRPT) has a recorded net income of -$535.98 million. SRPT has generated $0.11 earnings per share over the last four quarters.

What is Sarepta Therapeutics's price-to-earnings ratio?

Sarepta Therapeutics (NASDAQ:SRPT) has a trailing price-to-earnings ratio of 1,136.36 and a forward price-to-earnings ratio of 41.81.

What is Sarepta Therapeutics's EPS forecast for next year?

Sarepta Therapeutics's earnings are expected to grow from $2.99 per share to $8.18 per share in the next year, which is a 173.58% increase.


More Earnings Resources from MarketBeat

This page (NASDAQ:SRPT) was last updated on 6/13/2024 by MarketBeat.com Staff

From Our Partners